Dr Chantis Pharmaceuticals Private Limited

Dr Chantis Pharmaceuticals Private Limited - pharma in Ongole, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24240AP2015PTC096148 Incorporated 04 February 2015 ROC Vijayawada HQ Ongole, Andhra Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹24.75 Lakh
▲ 7% YoY
Net profit · FY 2022
₹27,036
Net margin 1.1%
EBITDA · FY 2022
₹70,018
EBITDA margin 2.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Dr Chantis Pharmaceuticals Private Limited

Data last updated:

Dr Chantis Pharmaceuticals Private Limited is a private limited company based in Ongole, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24240AP2015PTC096148. Its GSTIN is 37AAFCC9217K1ZC (Andhra Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Chanti'S Pharmaceuticals Private Limited. It is led by directors Chanti Sadasiva Reddy (Managing Director) and Chanti Venkata Reddy.

Its last annual general meeting (AGM) was held on 29 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Flat No. 15 16 17 1st Floor Surya Complex Guntur Road, Ongole, Andhra Pradesh, India – 523002.

As per the financials filed for FY 2022, the company reported a revenue of ₹24.75 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹27,036 (net margin 1.1%) and EBITDA of ₹70,018 (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 1% over five years.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website drchantis.com.

Company details

CIN U24240AP2015PTC096148
Registration Number 096148
Incorporation Date 04 February 2015
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant

Name history

Dr Chantis Pharmaceuticals has undergone 3 name changes throughout its history. The company was previously known as Chanti's Pharmaceuticals Private Limited, Dr. Chanti's Pharmaceuticals Private Limited, and Doctor Chantis Pharmaceuticals Private Limited. The current legal name is Dr Chantis Pharmaceuticals Private Limited.

Company NameStatus
Dr Chantis Pharmaceuticals Private LimitedCurrent
Chanti's Pharmaceuticals Private LimitedPrevious
Dr. Chanti's Pharmaceuticals Private LimitedPrevious
Doctor Chantis Pharmaceuticals Private LimitedPrevious

Contact details

Dr Chantis Pharmaceuticals Private Limited's registered office is in Ongole, Andhra Pradesh. Its website is drchantis.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No. 15 16 17 1st Floor Surya Complex Guntur Road, Ongole, Andhra Pradesh, India – 523002
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dr Chantis Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Dr Chantis Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Dr Chantis Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Dr Chantis Pharmaceuticals Private Limited, buy the company report.

Financials of Dr Chantis Pharmaceuticals Private Limited

FY 2022 filings available

Dr Chantis Pharmaceuticals Private Limited reported revenue of ₹24.75 Lakh (up 7% YoY) for FY 2022.

Revenue · FY 2022
₹24.75 Lakh ▲ 7%
Net profit · FY 2022
₹27,036 margin 1.1%
EBITDA · FY 2022
₹70,018 margin 2.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▼ 5%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 8%
5 years · compounded
▲ 38%

Revenue rose 7% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations₹24.75 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹70,018
Profit Before Tax
Tax Expense
Net Profit (PAT)₹27,036
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin2.8%
Net Profit Margin1.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dr Chantis Pharmaceuticals Private Limited, buy the company report.

Board of directors of Dr Chantis Pharmaceuticals Private Limited

Dr Chantis Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Chanti Sadasiva ReddyManaging Director04 Feb 201511 Years 8 MonthsCurrent
Chanti Venkata ReddyDirector04 Feb 201511 Years 8 MonthsCurrent

Auditor

Dr Chantis Pharmaceuticals Private Limited is audited by ANJIREDDY AND ASSOCIATES for the financial year 2021.

Auditor firmFinancial yearFirm registration number
ANJIREDDY AND ASSOCIATESFY 2021018872S

Shareholding

The shareholding of Dr Chantis Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dr Chantis Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dr Chantis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Dr Chantis Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AAFCC9217K1ZCAndhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Dr Chantis Pharmaceuticals Private Limited, buy the company report.

Recent activity

Dr Chantis Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Chanti Sadasiva Reddy was appointed as Managing Director on 04 Feb 2015.

AGM
Dr Chantis Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2022 as per latest MCA records.
Filing
Dr Chantis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada.
Appointed
Chanti Sadasiva Reddy was appointed as Managing Director.
Appointed
Chanti Venkata Reddy was appointed as Director.
Incorporation
04 Feb 2015
Dr Chantis Pharmaceuticals Private Limited was registered on 04 Feb 2015 with Roc Vijayawada & aged 11 years 8 months as per MCA records.

Frequently asked questions

Dr Chantis Pharmaceuticals is an active private limited company based in Ongole, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2015 (11+ years old) and is registered under CIN U24240AP2015PTC096148.

Dr Chantis Pharmaceuticals has 2 current directors:

The latest financial statements of Dr Chantis Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 29 September 2022. Year-wise statements from 2015 are in the company report.

The GSTIN of Dr Chantis Pharmaceuticals is 37AAFCC9217K1ZC, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Dr Chantis Pharmaceuticals is U24240AP2015PTC096148. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dr Chantis Pharmaceuticals was incorporated on 04 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Vijayawada.

Chanti Sadasiva Reddy was appointed as Managing Director on 04 Feb 2015. Chanti Venkata Reddy was appointed as Director on 04 Feb 2015.

Dr Chantis Pharmaceuticals can be reached through the website drchantis.com. Its registered office is in Ongole, Andhra Pradesh, India.

The registered office of Dr Chantis Pharmaceuticals is at Flat No. 15 16 17 1st Floor Surya Complex Guntur Road, Ongole, Andhra Pradesh, India – 523002.

Dr Chantis Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.